The Antipsychotic Paradox: What Nursing Homes Aren't Telling You
One facility achieved zero antipsychotic prescriptions, a stark contrast to the widespread use of sedatives. Here’s what that means for your family.
Get Palmelle in your Google results.
One tap. Google shows our reporting higher when you search.
A recent report from the Centers for Medicare & Medicaid Services (CMS) detailed a remarkable achievement: a long-stay nursing home where not a single resident was prescribed an antipsychotic medication in the first quarter of 2017 [c1]. This stands in sharp contrast to the national average, where in 2011, 23.9% of long-stay residents were on these powerful drugs, a figure that had only slightly dipped to 21.3% by late 2023 [c2][c3]. I read that CMS report while waiting for my mother’s pharmacy to call back about a new prescription for her anxiety. It made me wonder if the pharmacist on the other end was thinking about antipsychotics, or just the next one on the list. Because here’s my complaint about how this whole conversation usually goes: the narrative often focuses on reducing antipsychotics, which is good, but it overlooks the other chemicals being used to manage behavior. The typical industry response, when pressed on medication use, is about addressing specific symptoms to ensure resident safety and comfort. The Office of Inspector General (OIG) has noted that the overuse of antipsychotics presents a risk, particularly for those with dementia [c4]. However, the push to reduce these drugs often leads to an increase in other sedating medications, a point highlighted by Undark Magazine, which noted that antipsychotics themselves have sedating effects and are often used as a last resort for agitation or aggression [c5]. But what if a facility found a way to manage behaviors without *any* antipsychotics, and without a tidal wave of sedatives? That’s the real question. The CMS data shows it’s possible, and the OIG’s own report suggests that 80 percent of studied nursing facility residents were on psychotropic medications in November 2022, implying many are on more than just antipsychotics [c6]. The concrete move for families is to ask for a full list of *all* psychotropic medications a facility uses, not just antipsychotics. Specifically, ask about the prevalence of benzodiazepines and other sedatives used for behavioral management. This information should be as transparent as the antipsychotic data.
The direct answer
Achieving zero antipsychotic prescriptions in a nursing home is possible, as demonstrated by some facilities. However, it’s crucial to scrutinize the use of other psychotropic medications, particularly sedatives, which can also carry significant risks for older adults, especially those with dementia. Transparency about the full medication regimen is essential.
The Antipsychotic Reduction Goal: A Partial Victory
For years, the push has been to reduce the use of antipsychotic medications in nursing homes. The Centers for Medicare & Medicaid Services (CMS) has actively promoted initiatives to decrease these prescriptions, recognizing the serious side effects and risks associated with them, particularly for individuals with dementia. These drugs can increase the risk of stroke, falls, and even death.
Data shows progress. Between 2011 and 2017, national antipsychotic use in long-stay nursing home residents saw a reduction [c1]. However, this reduction often presents a complex picture. While the number of antipsychotic prescriptions may decrease, it doesn't automatically translate to better behavioral management or a reduction in overall medication use.
What’s often missing from the headline-grabbing reduction numbers is a deep dive into what replaces them. If antipsychotics are reduced, are residents then given higher doses of sedatives like benzodiazepines to manage agitation or sleep disturbances? This is where the real concern lies for many families.
The Rise of Sedatives: A Chemical Blanket?
When antipsychotics are tapered or discontinued, facilities may turn to other classes of drugs to manage challenging behaviors. Benzodiazepines, such as lorazepam or alprazolam, are frequently used for anxiety and agitation, but they are also potent sedatives. For older adults, especially those with cognitive impairments, these drugs can lead to grogginess, confusion, increased fall risk, and a general dulling of their personality and engagement.
The Undark Magazine reported that antipsychotics themselves have sedating effects and are often justified as a last resort for behaviors like aggression or wandering [c5]. This framing implies that managing these behaviors is the first thing, and if antipsychotics are off the table, another chemical means will be sought. The danger is that these 'other means' can be just as, if not more, problematic.
Consider the sheer volume. The Office of Inspector General (OIG) found that in November 2022, a staggering 80 percent of nursing facility residents studied were receiving psychotropic medications [c6]. This broad category includes antipsychotics, antidepressants, anxiolytics (anti-anxiety drugs), and sedatives. If antipsychotics represent a fraction of this 80%, it means a vast majority of residents are on some form of psychoactive drug, with sedatives potentially filling the gap left by reduced antipsychotics.
Want more of this?
Mark Palmelle a preferred source and it shows up when you search Google.
The 'Zero Antipsychotic' Facility: What Does It Really Mean?
A facility that reports zero antipsychotic prescriptions is certainly noteworthy. It suggests a commitment to non-pharmacological approaches and a deep understanding of behavioral triggers. These approaches might include environmental modifications, structured activities, specialized staff training in communication techniques for dementia, and individualized care plans that address the root causes of distress rather than just suppressing symptoms.
However, achieving 'zero antipsychotics' doesn't automatically mean 'zero sedatives.' Families must press for clarity on the full spectrum of psychotropic medications being used. What is the facility's policy on benzodiazepines or other sedating agents for behavioral management? Are they used sparingly, or as a primary intervention?
Transparency is the key. Ask for data not just on antipsychotics, but on the prevalence of sedative use. Understand the specific medications, dosages, and the conditions they are intended to treat. This level of detail is critical for assessing whether a facility is truly prioritizing person-centered care or simply swapping one set of chemical restraints for another.
Common mistakes
- Focusing solely on antipsychotic reduction.
While reducing antipsychotics is a vital goal, it's only part of the picture. Families need to ask about all psychotropic medications, especially sedatives, as they can have equally concerning side effects for older adults. - Accepting 'behavioral management' without probing the methods.
When a facility states they manage behaviors with medication, it's crucial to understand *which* medications and why. 'Behavioral management' can be a euphemism for sedation, not a comprehensive care plan.
Frequently asked
What are the risks of antipsychotic medications for older adults with dementia?
Antipsychotics can significantly increase the risk of serious health problems in older adults with dementia, including stroke, confusion, falls, and even death. They can also cause tremors, stiffness, and restlessness. These medications are generally not recommended for routine management of behavioral symptoms of dementia.
Are sedatives like benzodiazepines safe for older adults in care facilities?
Sedatives can be very risky for older adults, particularly those with dementia. They can cause excessive drowsiness, impaired coordination, dizziness, and an increased risk of falls. Long-term use can also lead to cognitive decline and dependence. They are often overused to manage agitation when other approaches could be more effective.
How can I find out what medications my parent is taking in a care facility?
You have the right to ask for a full list of your parent's current medications, including dosages and the reasons for each prescription. Specifically inquire about all psychotropic medications, including antipsychotics, sedatives, and anxiolytics. A facility's transparency on this matter is a key indicator of their care philosophy.
Sources
- CMS: Data show national partnership to improve dementia care achieves goals to reduce unnecessary antipsychotic medication use
- PALTmed: CMS Releases Latest Report on Antipsychotic Medication Use
- LTCCC Alert: Antipsychotic Drugs Administered to More Than One in Five Nursing Home Residents
- HHS OIG: Overuse of Antipsychotic Drugs in Nursing Homes Poses Risks to Residents
- Undark Magazine: Nursing Homes Overuse Chemical Restraints on Dementia Patients
- Justice in Aging: Why Too Many Psychotropic Medications in Nursing Facilities
More from Inside the Industry → · Back to Perch · Browse all stories
More of this, in your Google results.
Takes one tap, and it applies everywhere you search — not just this page.